Gritstone bio(US:GRTS) Prnewswire·2024-07-09 23:26Core Viewpoint - Levi & Korsinsky, LLP has initiated a class action securities lawsuit against Gritstone bio, Inc. due to alleged securities fraud impacting investors between March 9, 2023, and February 29, 2024 [6]. Group 1: Allegations Against Gritstone - The complaint alleges that Gritstone made false statements regarding its ability to launch the Phase 2b CORAL Study for its COVID-19 vaccine within the promised timeframe [4]. - It is claimed that Gritstone's inability to launch the study would hinder its ability to secure external funding, negatively affecting its balance sheet and cash position [4]. - The lawsuit asserts that Gritstone overstated its capability to develop and commercialize its products, leading to materially false and misleading public statements [4]. Group 2: Investor Information - Investors who suffered losses during the relevant timeframe have until August 6, 2024, to request appointment as lead plaintiff, although participation in any recovery does not require serving as lead plaintiff [5]. - Class members may be entitled to compensation without incurring any out-of-pocket costs or fees, with no obligation to participate [5].